Hypomethylation of FAM63B in bipolar disorder patients

Clinical Epigenetics

Volumn 8, Issue 1, 2016, Pages 1-6

  Starnawska, Anna ^a,b   Demontis, Ditte ^a,b   McQuillin, Andrew ^c   O’Brien, Niamh L ^c   Staunstrup, Nicklas H ^a,b,d   Mors, Ole ^b,d   Nielsen, Anders L ^a,b   Børglum, Anders D ^a,b   Nyegaard, Mette ^a,b  

^a AARHUS UNIVERSITY   (Denmark)

^b Lundbeck Foundation Initiative for Integrative Psychiatric Research   (Denmark)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Bipolar disorder; Candidate gene; DNA methylation; Epigenetics; FAM63B; iPLEX; Mental disorder

Indexed keywords

ARTICLE; B LYMPHOCYTE; BIPOLAR DISORDER; CELL COMPOSITION; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; FAM63B GENE; GENE; GENETIC ASSOCIATION; HUMAN; MAJOR CLINICAL STUDY; NATURAL KILLER CELL; PRIORITY JOURNAL; QUANTITATIVE TRAIT LOCUS; SINGLE NUCLEOTIDE POLYMORPHISM; T LYMPHOCYTE; EXON; GENETIC EPIGENESIS; GENETIC PREDISPOSITION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; SCHIZOPHRENIA;

FAM63B PROTEIN, HUMAN; PROTEIN; UBIQUITIN THIOLESTERASE;

BIPOLAR DISORDER; CPG ISLANDS; DNA METHYLATION; EPIGENESIS, GENETIC; EXONS; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; PROTEINS; SCHIZOPHRENIA; UBIQUITIN THIOLESTERASE;

EID: 84968796770     PISSN: 18687075     EISSN: 18687083     Source Type: Journal    
DOI: 10.1186/s13148-016-0221-6     Document Type: Article

References (27)

1. Lee SH, Ripke S, Neale BM, Faraone SV, Purcell SM, Perlis RH, et al. Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet. 2013;45:984–94.
2. Lichtenstein P, Yip BH, Björk C, Pawitan Y, Cannon TD, Sullivan PF, et al. Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study. Lancet. 2009;373:234–9.
3. Bambole V, Johnston M, Shah N, Sonavane S, Desouza A, Shrivastava A. Symptom overlap between schizophrenia and bipolar mood disorder: diagnostic issues. Open J Psychiatry. 2013;03:8–15.
4. Patel V, Prince M. Global mental health: a new global health field comes of age. JAMA. 2010;303:1976–7.
5. Dempster EL, Pidsley R, Schalkwyk LC, Owens S, Georgiades A, Kane F, et al. Disease-associated epigenetic changes in monozygotic twins discordant for schizophrenia and bipolar disorder. Hum Mol Genet. 2011;20:4786–96.
6. Chen C, Zhang C, Cheng L, Reilly JL, Bishop JR, Sweeney JA, et al. Correlation between DNA methylation and gene expression in the brains of patients with bipolar disorder and schizophrenia. Bipolar Disord. 2014;16:790–9.
7. Ruzicka WB, Subburaju S, Benes FM. Circuit- and diagnosis-specific DNA methylation changes at γ-aminobutyric acid-related genes in postmortem human hippocampus in schizophrenia and bipolar disorder. JAMA Psychiatry. 2015;72:541–51.
8. Pidsley R, Mill J. Epigenetic studies of psychosis: current findings, methodological approaches, and implications for postmortem research. Biol Psychiatry. 2011;69:146–56.
9. Aberg KA, McClay JL, Nerella S, Clark S, Kumar G, Chen W, et al. Methylome-wide association study of schizophrenia: identifying blood biomarker signatures of environmental insults. JAMA Psychiatry. 2014;71:255–64.
10. Purcell SM, Wray NR, Stone JL, Visscher PM, O’Donovan MC, Sullivan PF, et al. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature. 2009;460:748–52.
11. Endicott J, Spitzer RL. A diagnostic interview: the schedule for affective disorders and schizophrenia. Arch Gen Psychiatry. 1978;35:837–44.
12. Sklar P, Smoller JW, Fan J, Ferreira MAR, Perlis RH, Chambert K, et al. Whole-genome association study of bipolar disorder. Mol Psychiatry. 2008;13:558–69.
13. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet. 2006;38:904–9.
14. Scott LJ, Mohlke KL, Bonnycastle LL, Willer CJ, Li Y, Duren WL, et al. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science. 2007;316:1341–5.
15. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MAR, Bender D, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81:559–75.
16. Hannon E, Spiers H, Viana J, Pidsley R, Burrage J, Murphy TM, et al. Methylation QTLs in the developing brain and their enrichment in schizophrenia risk loci. Nat Neurosci. 2016;19:48–54.
17. Reinius LE, Acevedo N, Joerink M, Pershagen G, Dahlén S-E, Greco D, et al. Differential DNA methylation in purified human blood cells: implications for cell lineage and studies on disease susceptibility. PLoS One. 2012;7:e41361.
18. Laursen TM, Agerbo E, Pedersen CB. Bipolar disorder, schizoaffective disorder, and schizophrenia overlap. J Clin Psychiatry. 2009;70:1432–8.
19. Craddock N, Jones I. Genetics of bipolar disorder. J Med Genet. 1999;36:585–94.
20. Craddock N, O’Donovan MC, Owen MJ. The genetics of schizophrenia and bipolar disorder: dissecting psychosis. J Med Genet. 2005;42:193–204.
21. Ripke S, Neale BM, Corvin A, Walters JTR, Farh K-H, Holmans PA, et al. Biological insights from 108 schizophrenia-associated genetic loci. Nature. 2014;511:421–7.
22. Akbarian S, Liu C, Knowles JA, Vaccarino FM, Farnham PJ, Crawford GE, et al. The PsychENCODE project. Nat Neurosci. 2015;18:1707–12.
23. Houtepen LC, van Bergen AH, Vinkers CH, Boks MP. DNA methylation signatures of mood stabilizers and antipsychotics in bipolar disorder. Epigenomics. 2016;8:197–208.
24. Lonsdale J, Thomas J, Salvatore M, Phillips R, Lo E, Shad S, et al. The genotype-tissue expression (GTEx) project. Nat Genet. 2013;45:580–5.
25. Wu C, Macleod I, Su AI. BioGPS and MyGene.info: organizing online, gene-centric information. Nucleic Acids Res. 2013;41:D561–5.
26. Macchi MM, Bruce JN. Human pineal physiology and functional significance of melatonin. Front Neuroendocrinol. 2004;25:177–95.
27. Karatsoreos IN. Links between circadian rhythms and psychiatric disease. Front Behav Neurosci. 2014;8:162.